Skip to main content

Dr. Patrice Codogno

Posted June 19, 2023

"We have yet to reach the level where our basic scientific understanding of the molecular mechanisms of autophagy can be translated into clinically useful therapies."

I’m Patrice Codogno, and this is why I research.

Dr. Patrice Codogno is the Research Director of the French Institute for Health and Medical research (INSERM) and a group leader at the Institut Necker-Enfants Malades (INEM). His research is dedicated to basic aspects of autophagy, including membrane dynamics, autophagy signaling and the role of autophagy in the stress response to mechanical stress and cancer treatment. Patrice Codogno obtained his PhD in 1984 from the University Pierre et Marie Curie in Paris. He obtained a permanent junior researcher position at INSERM in 1985. He became a group leader in 1989. His research was focused on glycoprotein biosynthesis, trafficking and degradation. From 1999 to 2012 he was the Director of an INSERM laboratory with focus on glycobiology and autophagy. His interest in autophagy started in the mid ‘90s and became his major focus following his discovery in collaboration with Alfred J Meijer (AMC, Amsterdam, NL) in 2000 of the dual role of class I and class III phosphatidylinositol 3-kinase (PI3K) in the regulation of autophagy in mammalian cells. In 2013, Patrice Codogno joined INEM at the Necker Hospital site to start a research group solely dedicated to the study of autophagy from basic research to physio and pathophysiological aspects of autophagy. Patrice Codogno co-chaired (with Fulvio Reggiori, University of Groningen, Groningen, NL) the 2016 Gordon Research Conference on Autophagy in stress, development and disease. He is the vice-chair (chair Caty Casas Louzao, UAB, Barcelone, Spain) of the COST action “Transautophagy” and was the first president of the French Autophagy network (CFATG) founded in 2011.

Would you tell us what sparked your interest in basic science?

I developed my interest in basic science during my scientific courses in Paris at the University Pierre et Marie Curie. Some of the professors tickled my curiosity about the origin of life and the intimate functioning of cells.

You have made important discoveries in Autophagy. Is there one particular experiment or discovery you feel most proud of? An ‘aha moment’?

I believe that the most important discovery by my group was of the distinct role of phosphoinositol 3 kinases in mammalian autophagy with class III PI3K being an activator and class I an inhibitor.

Tell us more about the questions your lab is currently investigating and where you see your research moving in the future?

We have three main lines of research in the lab. First, we study the role of membrane dynamics during the early phase of autophagosome biogenesis. Second, we are analyzing how autophagy integrates into the cellular response to mechanical stress via the primary cilium. Third, we are attempting to develop new drugs to target autophagy in cancer cells. These lines are for the present and for our future research.

Your research has helped characterize the molecular mechanisms regulating autophagy. To you, what important questions in the field of autophagy are left unanswered?

We have yet to reach the level where our basic scientific understanding of the molecular mechanisms of autophagy can be translated into clinically useful therapies. Although I believe that significant progress is being made in this area, we lack an understanding of the early events in autophagosome formation such as membrane dynamics, and we need to identify bio-markers that will allow us to determine when autophagy levels are abnormal either resulting from or causing pathological situations.

Patrice Codogno Lab

Describe why your research is important to the ordinary citizen.

Autophagy allows a cell to respond to stress situations via its limited auto-digestion. How this auto-digestion is controlled to avoid cell demise and how we can modulate this auto-digestion is key to the development of new therapeutic approaches for treatment of diseases like cancer that touch all of our lives directly or indirectly.

Outside of autophagy, what research do you find especially exciting right now?

The origin of universe: the very first moments after the big bang and the mechanism of evolution of species – especially the evolution of hominids – I find to be fascinating subjects.

Do you have any advice for someone interested in a tenure track position?

To do, to do, and to do it again. To be strong-willed and persevering. To know when to listen to or not to listen to external advice.

And finally, if you could have one superpower, what superpower would that be?

The superpower to have no superpower - because here comes to my mind the myth of the Midas king and his golden touch…Being human and acting as a human being is in principle a wonderful power.